Relief Therapeutics Holding (XSWX:RLF) Change In Inventory: CHF-0.55 Mil (TTM As of Jun. 2025)


XSWX:RLF Relief Therapeutics Holding SA XSWX:RLF
20 GF Score
Price CHF3.00
GF Value CHF6.28
! 5 Warning Signs
View Full Analysis

What is Relief Therapeutics Holding Change In Inventory?

Relief Therapeutics Holding XSWX:RLF +4.90% 20 Change In Inventory is CHF-0.55 Mil as of Jun. 2025. GuruFocus rates XSWX:RLF with a GF Score™ of 20/100 and a GF Value™ of CHF6.28. The stock has 5 warning signs investors should review.

Relief Therapeutics Holding's change in inventory for the quarter that ended in Jun. 2025 was CHF0.12 Mil. It means Relief Therapeutics Holding's inventory declined by CHF0.12 Mil from Dec. 2024 to Jun. 2025 .

Relief Therapeutics Holding's change in inventory for the fiscal year that ended in Dec. 2024 was CHF-0.49 Mil. It means Relief Therapeutics Holding's inventory increased by CHF0.49 Mil from Dec. 2023 to Dec. 2024 .

Relief Therapeutics Holding's Total Inventories for the quarter that ended in Jun. 2025 was CHF0.92 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Relief Therapeutics Holding's Days Inventory for the quarter that ended in Jun. 2025 was 299.34.

Inventory Turnover measures how fast the company turns over its inventory within a year. Relief Therapeutics Holding's Inventory Turnover for the quarter that ended in Jun. 2025 was 0.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Relief Therapeutics Holding's Inventory-to-Revenue for the quarter that ended in Jun. 2025 was 0.81.

Relief Therapeutics Holding  (XSWX:RLF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Relief Therapeutics Holding's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.9825/0.599*365 / 2
=299.34

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Relief Therapeutics Holding's Inventory Turnover for the quarter that ended in Jun. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.599 / 0.9825
=0.61

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Relief Therapeutics Holding's Inventory to Revenue for the quarter that ended in Jun. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.9825 / 1.218
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relief Therapeutics Holding Change In Inventory Related Terms

Relief Therapeutics Holding Change In Inventory Historical Data

* Premium members only.

The historical data trend for Relief Therapeutics Holding's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relief Therapeutics Holding Change In Inventory Chart

Relief Therapeutics Holding Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.11 0.16 -0.33 -0.49

Relief Therapeutics Holding Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.11 0.18 -0.67 0.12
XSWX:RLF
20GF Score
Relief Therapeutics Holding SA XSWX:RLF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Relief Therapeutics Holding Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of CHF-0.55 Mil mean?
Relief Therapeutics Holding (XSWX:RLF) has a Change In Inventory of CHF-0.55 Mil as of Jun. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Relief Therapeutics Holding and its competitors.
Is Relief Therapeutics Holding's Change In Inventory too high?
Relief Therapeutics Holding's current Change In Inventory is CHF-0.55 Mil. Overall, Relief Therapeutics Holding has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Relief Therapeutics Holding's Change In Inventory compare to KTTA and OSRH?
Relief Therapeutics Holding's Change In Inventory of CHF-0.55 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Relief Therapeutics Holding and its competitors. Relief Therapeutics Holding's current Change In Inventory is CHF-0.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relief Therapeutics Holding stock overvalued right now?
Relief Therapeutics Holding (XSWX:RLF) has a current Change In Inventory of CHF-0.55 Mil. The stock's GF Value™ is CHF6.28, compared to a current price of CHF3.00 — trading 52.2% below its estimated fair value. The current Change In Inventory is CHF-0.55 Mil. Relief Therapeutics Holding's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Relief Therapeutics Holding (XSWX:RLF), the current Change In Inventory is CHF-0.55 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Relief Therapeutics Holding (XSWX:RLF) Overvalued in 2026?

Based on GuruFocus' analysis, Relief Therapeutics Holding stock appears to be undervalued. The current stock price of CHF3.00 is trading 52.2% below its estimated GF Value™ of CHF6.28.

Key valuation signals for XSWX:RLF:

  • Change In Inventory: CHF-0.55 Mil
  • GF Value™: CHF6.28 vs. price of CHF3.00 (52.2% below fair value)
  • GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the XSWX:RLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Relief Therapeutics Holding Business Description

Address Avenue de Secheron 15, Geneva, CHE, 1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products, and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development, such as RLF-TD011 and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast, among others. Geographically, the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
20GF Score

Get the complete analysis for XSWX:RLF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF3.00
Price
CHF6.28
GF Value